FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers

Completed · Phase 1

Conditions studied: Chronic Wounds, Diabetes, Venous Stasis Ulcers

In brief

FGF-1 is being used for the treatment of patients with diabetic or venous stasis ulcers. Procedure includes topical administration of FGF-1 or placebo and evaluation of safety, pharmacokinetics, and wound improvement.

Key facts

Study ID

NCT00425178

Run by

CardioVascular BioTherapeutics, Inc.

People needed

8

Starts

2005-09-02

Expected to finish

2006-12-01

Last updated by the study team

2019-11-01

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Warren General Hospital — Warren, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.